{"count": 4, "results": [{"_id": "32526091", "pmid": 32526091, "title": "Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.", "journal": "Cochrane Database Syst Rev", "authors": ["Griffith RJ", "Alsweiler J", "Moore AE", "Brown S", "Middleton P", "Shepherd E", "Crowther CA"], "date": "2020-06-11T00:00:00Z", "doi": "10.1002/14651858.CD012394.pub3", "meta_date_publication": "2020 Jun 11", "meta_volume": "6", "meta_issue": "6", "meta_pages": "CD012394", "score": 50223.45, "text_hl": "Pharmaceutical Possible benefit: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ versus placebo given to @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ pregnant @SPECIES_9606 @@@women@@@ possibly reduced the risk of @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@GDM@@@: RR 0.85, 95% CI 0.61 to 1.19; 3 trials; 892 @SPECIES_9606 @@@women@@@; moderate-quality evidence. ", "citations": {"NLM": "Griffith RJ, Alsweiler J, Moore AE, Brown S, Middleton P, Shepherd E, Crowther CA. Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2020 Jun 11;6(6):CD012394. PMID: 32526091", "BibTeX": "@article{32526091, title={Interventions to prevent women from developing gestational diabetes mellitus: an overview of Cochrane Reviews.}, author={Griffith RJ and Alsweiler J and Moore AE and Brown S and Middleton P and Shepherd E and Crowther CA}, journal={Cochrane Database Syst Rev}, volume={6}, number={6}, pages={CD012394}}"}}, {"_id": "31334867", "pmid": 31334867, "title": "Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.", "journal": "Fundam Clin Pharmacol", "authors": ["Hu J", "Zhang J", "Zhu B"], "date": "2019-12-01T00:00:00Z", "doi": "10.1111/fcp.12501", "meta_date_publication": "2019 Dec", "meta_volume": "33", "meta_issue": "6", "meta_pages": "649-658", "score": 50048.188, "text_hl": "The results showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ improved @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-induced @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Proteinuria @DISEASE_MESH:D011507 @@@proteinuria@@@, @DISEASE_Fetal_Growth_Retardation @DISEASE_MESH:D005317 @@@fetal growth restriction@@@ (@DISEASE_Fetal_Growth_Retardation @DISEASE_MESH:D005317 @@@FGR@@@) and @<m>DISEASE_Stillbirth</m> @DISEASE_MESH:D050497 @@@stillbirth@@@, alleviated @DISEASE_Placenta_Diseases @DISEASE_MESH:D010922 @@@placental injury@@@ and decreased maternal serum marker @GENE_AFP @GENE_24177 @@@alpha-fetoprotein@@@ (@GENE_MTR @GENE_81522 @@@MS@@@-@GENE_AFP @GENE_24177 @@@AFP@@@) level; @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ suppressed @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-induced @GENE_TNF @GENE_24835 @@@TNF-alpha@@@ and @GENE_IL6 @GENE_24498 @@@IL-6@@@ productions, reduced oxidative/nitrative stress as evidenced by increased superoxide dismutase (SOD) activity, decreased @GENE_NOS2 @GENE_24599 @@@inducible nitric oxide synthase@@@ (@GENE_NOS2 @GENE_24599 @@@iNOS@@@) activity, and decreased levels of @CHEMICAL_Malondialdehyde @CHEMICAL_MESH:D008315 @@@malondialdehyde@@@ (@CHEMICAL_Malondialdehyde @CHEMICAL_MESH:D008315 @@@MDA@@@) and @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@ (NO); @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ inhibited @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-induced NF-kappaB activation in placentas. ", "citations": {"NLM": "Hu J, Zhang J, Zhu B. Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia. Fundam Clin Pharmacol. 2019 Dec;33(6):649-658. PMID: 31334867", "BibTeX": "@article{31334867, title={Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia.}, author={Hu J and Zhang J and Zhu B}, journal={Fundam Clin Pharmacol}, volume={33}, number={6}, pages={649-658}}"}}, {"_id": "29215149", "pmid": 29215149, "title": "Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.", "journal": "Br J Clin Pharmacol", "authors": ["Panchaud A", "Rousson V", "Vial T", "Bernard N", "Baud D", "Amar E", "De Santis M", "Pistelli A", "Dautriche A", "Beau-Salinas F", "Cassina M", "Dunstan H", "Passier A", "Kaplan YC", "Duman MK", "Maňáková E", "Eleftheriou G", "Klinger G", "Winterfeld U", "Rothuizen LE", "Buclin T", "Csajka C", "Hernandez-Diaz S"], "date": "2018-03-01T00:00:00Z", "doi": "10.1111/bcp.13481", "meta_date_publication": "2018 Mar", "meta_volume": "84", "meta_issue": "3", "meta_pages": "568-578", "score": 50048.188, "text_hl": "The risk of @DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@pregnancy losses@@@ (@DISEASE_Abortion_Spontaneous @DISEASE_MESH:D000022 @@@spontaneous abortions@@@ and @<m>DISEASE_Stillbirth</m> @DISEASE_MESH:D050497 @@@stillbirths@@@) was 20.8% in @SPECIES_9606 @@@women@@@ on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ during the first trimester and 10.8% in the reference group [adjusted hazard ratio (HR) 1.57; 95% CI 0.90-2.74]. ", "citations": {"NLM": "Panchaud A, Rousson V, Vial T, Bernard N, Baud D, Amar E, De Santis M, Pistelli A, Dautriche A, Beau-Salinas F, Cassina M, Dunstan H, Passier A, Kaplan YC, Duman MK, Maňáková E, Eleftheriou G, Klinger G, Winterfeld U, Rothuizen LE, Buclin T, Csajka C, Hernandez-Diaz S. Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services. Br J Clin Pharmacol. 2018 Mar;84(3):568-578. PMID: 29215149", "BibTeX": "@article{29215149, title={Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.}, author={Panchaud A and Rousson V and Vial T and Bernard N and Baud D and Amar E and De Santis M and Pistelli A and Dautriche A and Beau-Salinas F and Cassina M and Dunstan H and Passier A and Kaplan YC and Duman MK and Maňáková E and Eleftheriou G and Klinger G and Winterfeld U and Rothuizen LE and Buclin T and Csajka C and Hernandez-Diaz S}, journal={Br J Clin Pharmacol}, volume={84}, number={3}, pages={568-578}}"}}, {"_id": "30039871", "pmid": 30039871, "title": "Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.", "journal": "Cochrane Database Syst Rev", "authors": ["Dodd JM", "Grivell RM", "Deussen AR", "Hague WM"], "date": "2018-07-24T00:00:00Z", "doi": "10.1002/14651858.CD010564.pub2", "meta_date_publication": "2018 Jul 24", "meta_volume": "7", "meta_issue": "7", "meta_pages": "CD010564", "score": 50038.65, "text_hl": "We did not identify studies of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in combination with another treatment. ", "citations": {"NLM": "Dodd JM, Grivell RM, Deussen AR, Hague WM. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. PMID: 30039871", "BibTeX": "@article{30039871, title={Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.}, author={Dodd JM and Grivell RM and Deussen AR and Hague WM}, journal={Cochrane Database Syst Rev}, volume={7}, number={7}, pages={CD010564}}"}}]}